Showing results (261-270 of 584) with videos related to

Sort By:
Pageof 59
JAMA Oncology|May 29, 2025
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung CancerArianna Marinello, Maria Rosa Ghigna, Julia K Rotow, et al.
The Lancet. Oncology|July 3, 2026
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trialLeonardo Brunetti, Valentina Santo, David J Pinato, et al.
Oncoimmunology|April 7, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancersRoxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
ESMO Open|June 26, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancerAntonio Passaro, Alfredo Addeo, Christophe Von Garnier, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patientsFrederic Deschamps, Lambros Tselikas, Steven Yevich, et al.
Oncoimmunology|July 4, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancerLéa Montégut, Adrien Rousseau, Cinzia Ungolo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective studyAlice Boileve, Laurence Albiges, Michel Ducreux, et al.
Investigational New Drugs|November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitorsPierre Loulergue, Mansouria Merad, Romain Coriat, et al.
JTO Clinical and Research Reports|May 2, 2022
Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case ReportMariona Riudavets, Benjamin Wyplosz, Maria Rosa Ghigna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancerFiona Blackhall, Dong-Wan Kim, Benjamin Besse, et al.
Pageof 59